Arthur A. Levin, Director at Avidity Biosciences, Inc. (RNA), sold 5,000 shares at $29.90 ($150K) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Scheduled sale ($150k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |